GO:0048541 Peyer's patch development: Mucosal Immunity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048541 Peyer's patch development describes the progression of Peyer's patches from formation to mature structure, including the establishment of distinct B- and T-cell zones for lymphocyte activation.
• Peyer's patches are gut-associated lymphoid tissue (GALT) nodules that serve as inductive sites for mucosal adaptive immunity.
• Key cellular and molecular requirements include lymphoid tissue inducer cells, cytokines such as IL-7 and lymphotoxin, and transcription factors like BOB.1/OBF.1.
• M cell maturation and conventional dendritic cell (cDC) activation determine the onset of adaptive immune priming in the neonatal Peyer's patch.
• Peyer's patch B cells can sample transglutaminase-gluten complexes and drive celiac disease autoimmunity.
• In ruminants, Peyer's patches serve as a site of B-cell development, highlighting species-specific differences.
Description
Peyer's patches are organized lymphoid follicles located in the small intestinal mucosa, and their development is a critical process for establishing mucosal immune surveillance. The Gene Ontology term GO:0048541, Peyer's patch development, captures the progression of these structures from initial formation to a mature architecture containing distinct B- and T-cell zones that support lymphocyte activation. Understanding this process is essential for researchers studying mucosal immunity, vaccine responses, and inflammatory diseases of the gut.
Peyer's patch development At A Glance
| GO ID | GO:0048541 |
|---|---|
| GO term | Peyer's patch development |
| Ontology | biological_process |
| Synonym | GALT development, gut-associated lymphoid tissue development |
| Major function | Formation and maturation of gut-associated lymphoid tissue nodules for lymphocyte activation |
| Related process | Mucosal immunity, lymphoid organogenesis |
| Key cell types | Lymphoid tissue inducer cells, B cells, T cells, M cells, dendritic cells |
| Species relevance | Mouse, human, sheep, cattle |
What Is GO:0048541?
Peyer's patch development (GO:0048541) is the biological process whose specific outcome is the progression of Peyer's patches over time, from their formation to the mature structure. Peyer's patches are typically found as nodules associated with gut epithelium with distinct internal structures including B- and T-zones for the activation of lymphocytes.
Why Is Peyer's patch development Important in Cell Biology?
Peyer's patch development is fundamental to mucosal immunity because these structures are the primary inductive sites for immune responses in the gut. Defects in this process can lead to impaired immune priming and increased susceptibility to enteric infections. Moreover, Peyer's patches are involved in the pathogenesis of autoimmune conditions such as celiac disease, where B cells sample gluten complexes and drive autoimmunity. Therefore, understanding the molecular and cellular mechanisms of Peyer's patch development has broad implications for vaccine design, autoimmune disease research, and gut homeostasis.
• Provides the anatomical basis for mucosal immune surveillance and antigen sampling.
• Critical for neonatal adaptive immune priming and M cell maturation.
• Involved in the pathogenesis of celiac disease through B cell-mediated autoimmunity.
• Requires coordinated action of lymphoid tissue inducer cells and cytokines.
• Transcription factor BOB.1/OBF.1 is essential for normal Peyer's patch development.
• Species differences exist, with ruminant Peyer's patches supporting B-cell development.
• Dysregulation may contribute to inflammatory bowel diseases and food allergies.
• Serves as a model for studying lymphoid organogenesis in general.
What Happens During Peyer's patch development?
Initiation and lymphoid tissue inducer cell recruitment
In simple terms: Special cells called lymphoid tissue inducer cells gather at specific spots in the gut to start forming Peyer's patches.
Peyer's patch development begins with the recruitment of lymphoid tissue inducer (LTi) cells to the gut epithelium. These cells interact with stromal cells and initiate a cascade of signaling events, including lymphotoxin and cytokine signaling, that are essential for the formation of lymphoid follicles. Cytokines such as IL-7 and lymphotoxin are critical regulators of this early phase.
Formation of B- and T-cell zones
In simple terms: The patch organizes into separate areas for B cells and T cells, which are needed for immune activation.
As development progresses, Peyer's patches acquire distinct internal structures including B-cell follicles and T-cell zones. This organization is crucial for the activation of lymphocytes and the initiation of adaptive immune responses. The transcription factor BOB.1/OBF.1 is required for this process, as its deficiency leads to impaired Peyer's patch development.
M cell maturation and cDC activation
In simple terms: Specialized epithelial cells called M cells mature and help activate dendritic cells, which determine when the immune system starts responding.
M cell maturation and conventional dendritic cell (cDC) activation are key events that determine the onset of adaptive immune priming in the neonatal Peyer's patch. These processes enable efficient antigen sampling and presentation to lymphocytes, bridging innate and adaptive immunity.
Species-specific variations
In simple terms: Different animals have slightly different Peyer's patch structures and functions.
In sheep and cattle, Peyer's patches serve as a site of B-cell development, which differs from the typical role in mice and humans where they are primarily inductive sites for immune responses. This highlights the importance of considering species-specific differences in Peyer's patch biology.
Key Genes Involved in GO:0048541 Peyer's patch development
The following genes and proteins have been implicated in Peyer's patch development based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BOB.1/OBF.1 | Transcription factor required for Peyer's patch development | Deficiency leads to impaired development |
| IL-7 | Cytokine essential for lymphoid tissue inducer cell function | Regulates early Peyer's patch organogenesis |
| Lymphotoxin | Cytokine involved in lymphoid follicle formation | Critical for Peyer's patch development |
| RORγt | Transcription factor for lymphoid tissue inducer cells | Required for Peyer's patch initiation |
| CXCL13 | Chemokine for B cell recruitment | Guides B cell organization in follicles |
| CCL19 | Chemokine for T cell and dendritic cell recruitment | Organizes T cell zones |
| CCL21 | Chemokine for T cell and dendritic cell recruitment | Organizes T cell zones |
| TNFSF11 (RANKL) | Cytokine involved in lymphoid tissue development | May influence Peyer's patch formation |
| TNFSF14 (LIGHT) | Cytokine involved in lymphoid organogenesis | Contributes to Peyer's patch development |
| IL-7R | Receptor for IL-7 | Mediates IL-7 signaling in LTi cells |
| LTβR | Receptor for lymphotoxin | Essential for lymphoid tissue development |
| NIK | Kinase in non-canonical NF-κB pathway | Downstream of LTβR signaling |
| IKKα | Kinase in non-canonical NF-κB pathway | Required for lymphoid organogenesis |
| RelB | Transcription factor in non-canonical NF-κB pathway | Critical for Peyer's patch development |
| ID2 | Transcription factor for LTi cell differentiation | Required for LTi cell development |
| RANK | Receptor for RANKL | May regulate Peyer's patch development |
| Transglutaminase | Enzyme that modifies gluten peptides | Involved in celiac disease autoimmunity in Peyer's patches |
How Is Peyer's patch development Regulated?
Peyer's patch development is regulated by a complex network of cytokines and transcription factors. Cytokines such as IL-7 and lymphotoxin are critical for the initiation and progression of the process. The non-canonical NF-κB pathway, involving NIK, IKKα, and RelB, is essential for lymphoid organogenesis. Additionally, the transcription factor BOB.1/OBF.1 is required for normal Peyer's patch development, as its deficiency leads to impaired development. M cell maturation and cDC activation also regulate the onset of adaptive immune priming in neonatal Peyer's patches.
Peyer's patch development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BOB.1/OBF.1 | Impaired Peyer's patch development | Knockout mouse |
| Transglutaminase | Celiac disease autoimmunity | Knock-in mouse expressing human transglutaminase |
| IL-7 | Lymphoid tissue inducer cell deficiency | Knockout mouse |
| Lymphotoxin | Lymphoid organogenesis defects | Knockout mouse |
| RORγt | Lymphoid tissue inducer cell deficiency | Knockout mouse |
Celiac disease
Peyer's patch B cells can sample transglutaminase-gluten complexes and drive celiac disease autoimmunity. This highlights the role of Peyer's patches in the pathogenesis of celiac disease, where aberrant immune responses to gluten lead to intestinal damage.
Inflammatory bowel disease
Dysregulation of Peyer's patch development and function may contribute to inflammatory bowel diseases, as these structures are key inductive sites for mucosal immunity. Impaired immune priming in the gut can lead to chronic inflammation.
Immunodeficiency
Defects in Peyer's patch development can result in impaired mucosal immune responses and increased susceptibility to enteric infections. Understanding the molecular requirements, such as BOB.1/OBF.1, is important for diagnosing and treating immunodeficiencies.
From Peyer's patch development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of BOB.1/OBF.1 in Peyer's patch development | Knockout mouse |
| Cytokine requirements for Peyer's patch organogenesis | Knockout mouse for IL-7 or lymphotoxin |
| M cell maturation and cDC activation in neonatal Peyer's patches | Neonatal mouse models |
| Species-specific differences in Peyer's patch function | Sheep and cattle models |
| Transglutaminase-gluten complex sampling in celiac disease | Humanized mouse models |
| Lymphoid tissue inducer cell development | RORγt knockout mouse |
How to Study the Peyer's patch development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Histology | Tissue architecture and cell distribution | Visualizing Peyer's patch structure |
| Immunofluorescence | Protein expression and localization | Identifying B- and T-cell zones |
| Flow cytometry | Cell surface markers and populations | Quantifying immune cell subsets |
| Single-cell RNA-seq | Transcriptomes of individual cells | Discovering cell heterogeneity |
| Knockout mouse | Gene function in vivo | Testing requirement of specific genes |
| Reporter mouse | Gene expression dynamics | Tracking developmental processes |
| Organoid culture | In vitro modeling of gut tissue | Studying epithelial-immune interactions |
Histology and immunofluorescence
Histological and immunofluorescence techniques are used to visualize the structure of Peyer's patches, including B- and T-cell zones, and to assess the maturation state. These methods are essential for confirming the presence and organization of lymphoid follicles.
Flow cytometry
Flow cytometry allows the quantification and characterization of immune cell populations within Peyer's patches, such as B cells, T cells, dendritic cells, and M cells. This technique is crucial for understanding the cellular composition and activation states.
Single-cell RNA sequencing
Single-cell RNA sequencing provides a comprehensive view of gene expression heterogeneity within Peyer's patches, revealing distinct cell subsets and their developmental trajectories. This method is powerful for identifying novel regulators of Peyer's patch development.
Genetically engineered mouse models
Knockout and transgenic mouse models are indispensable for studying the function of specific genes in Peyer's patch development. These models allow researchers to dissect the molecular pathways involved in lymphoid organogenesis.
How CRISPR Can Be Used to Study GO:0048541 Peyer's patch development
Knockout
CRISPR knockout models are used to disrupt genes suspected to be involved in Peyer's patch development, such as BOB.1/OBF.1, to assess their requirement for lymphoid organogenesis. These models help validate findings from knockout mice and can be applied to other species.
Point Mutation
Point mutations can be introduced to model specific human variants or to dissect functional domains of proteins involved in Peyer's patch development. For example, mutations in cytokine receptors or transcription factors can reveal critical signaling residues.
Knock-in
Knock-in models allow the expression of tagged or humanized proteins to track their localization and function in Peyer's patches. This is particularly useful for studying human-specific aspects of mucosal immunity.
Overexpression
Overexpression of candidate genes can be achieved via CRISPR activation or transgenic approaches to test sufficiency in driving Peyer's patch development or altering immune responses.
How EDITGENE Supports Peyer's patch development Research
Researchers studying Peyer's patch development-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic modifications in relevant cell models and animal models, accelerating functional validation and therapeutic target discovery.
Contact EDITGENE today to design your custom CRISPR model for Peyer's patch development research.
Frequently Asked Questions About Peyer's patch development
What is Peyer's patch development?
Peyer's patch development (GO:0048541) is the biological process by which Peyer's patches, which are gut-associated lymphoid tissue nodules, progress from formation to a mature structure with distinct B- and T-cell zones for lymphocyte activation.
What genes are involved in Peyer's patch development?
Key genes include BOB.1/OBF.1, IL-7, lymphotoxin, RORγt, and various chemokines and cytokines that regulate lymphoid tissue inducer cells and follicle formation.
Why are Peyer's patches important for immunity?
Peyer's patches are the primary inductive sites for mucosal immune responses, sampling antigens from the gut and initiating adaptive immunity against pathogens.
How is Peyer's patch development studied?
Researchers use histological techniques, flow cytometry, single-cell RNA sequencing, and genetically engineered mouse models to study Peyer's patch development.
What diseases are associated with Peyer's patch dysfunction?
Dysfunction of Peyer's patches is associated with celiac disease, inflammatory bowel diseases, and immunodeficiency.
What is the role of BOB.1/OBF.1 in Peyer's patch development?
BOB.1/OBF.1 is a transcription factor required for normal Peyer's patch development; its deficiency leads to impaired development.
How do M cells contribute to Peyer's patch function?
M cells are specialized epithelial cells that mature in Peyer's patches and facilitate antigen sampling and presentation to dendritic cells, determining the onset of adaptive immune priming.
Are there species differences in Peyer's patch development?
Yes, in sheep and cattle, Peyer's patches serve as a site of B-cell development, which differs from their primary role as inductive sites in mice and humans.
What cytokines regulate Peyer's patch development?
IL-7 and lymphotoxin are critical cytokines that regulate the initiation and progression of Peyer's patch development.
Can CRISPR be used to study Peyer's patch development?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function in Peyer's patch development.
Conclusion
Peyer's patch development (GO:0048541) is a complex biological process essential for mucosal immunity. It involves the coordinated action of lymphoid tissue inducer cells, cytokines, and transcription factors that build organized lymphoid follicles with distinct B- and T-cell zones. Dysregulation of this process is linked to diseases such as celiac disease and inflammatory bowel diseases. Continued research using advanced CRISPR models and single-cell technologies will further unravel the molecular mechanisms and provide new therapeutic opportunities.
References
- 1. du Pré MF et al.. 2025. Peyer's Patch B Cells Sample Transglutaminase-Gluten Complexes and Drive Celiac Disease Autoimmunity.. Gastroenterology 169(7):1450-1461 PMID: 40602545
- 2. Betzler AC et al.. 2021. Impaired Peyer's patch development in BOB.1/OBF.1-deficient mice.. Eur J Immunol 51(7):1860-1863 PMID: 33733501
- 3. Yasuda M et al.. 2006. The sheep and cattle Peyer's patch as a site of B-cell development.. Vet Res 37(3):401-15 PMID: 16611555
- 4. Torow N et al.. 2023. M cell maturation and cDC activation determine the onset of adaptive immune priming in the neonatal Peyer's patch.. Immunity 56(6):1220-1238.e7 PMID: 37130522
- 5. Kiyono H et al.. 2004. NALT- versus Peyer's-patch-mediated mucosal immunity.. Nat Rev Immunol 4(9):699-710 PMID: 15343369
- 6. Mayrhofer G. 1997. Peyer's patch organogenesis--cytokines rule, OK?. Gut 41(5):707-9 PMID: 9414984
- 8. Coles M et al.. 2010. Cellular and molecular requirements in lymph node and Peyer's patch development.. Prog Mol Biol Transl Sci 92:177-205 PMID: 20800822
